Manuscripts

Search by keyword or author name.

Showing 1459 manuscripts.

Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097

Diana F Clarke, Jos Lommerse, Edward P Acosta,  Mae P Cababasay, Jiajia Wang, Stephen A Spector, Anne Chain, Elizabeth Smith, Hedy Teppler, Rohan Hazra, Kat Calabrese, Bobbie Graham, Stephanie Popson, Yvonne Bryson, Mark Mirochnick, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1097 Study Team. Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097. Journal of Acquired Immune Deficiency Syndromes. 2021. 85: 626-634. PMID: 32925360

Journal

Journal of Acquired Immune Deficiency Syndromes

Study

P1097

Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children

Ruth A Karron, Jessica E Atwell, Elizabeth J McFarland, Coleen K Cunningham, Petronella Muresan, Charlotte Perlowski, Jennifer Libous, Stephen A Spector, Ram Yogev, Mariam Aziz, Suzanne Woods, Kimberli Wanionek, Peter L Collins, Ursula J Buchholz. Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children. American Journal of Respiratory and Critical Care Medicine. 2021. PMID: 32871092

Journal

American Journal of Respiratory and Critical Care Medicine

Safety and efficacy of 48 and 96 weeks of alendronate in children and adolescents with perinatal HIV infection and low bone mineral density for age

J C Lindsey, D L Jacobson, H Spiegel, C M Gordon, R Hazra, G K Siberry, IMPAACT P1076 Study Team. Safety and efficacy of 48 and 96 weeks of alendronate in children and adolescents with perinatal HIV infection and low bone mineral density for age. Clinical Infectious Diseases. 2021. PMID: 32584996

Journal

Clinical Infectious Diseases

Study

P1076

Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV

Debika Bhattacharya, Rong Guo, Chi-Hong Tseng, Lynda Emel, Ren Sun, Shih-Hsin Chiu, Lynda Stranix-Chibanda, Tsungai Chipato, Neaka Mohtashemi, Kenneth Kintu, Karim Manji, Dhayendre Moodley, Chloe Thio, Yvonne Maldonado, Judith Currier. Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV. Pediaric Infectious Disease Journal. 2021. PMID: 33181788

Journal

Pediaric Infectious Disease Journal

Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study

Theodore Ruel, Edmund Capparelli, Camlin Tierney, Bryan Nelson, Anne Coletti, Yvonne Bryson, Mark Cotton, Stephen Spector, Mark Mirochnick, Rebecca LeBlanc, Christina Reding, Bonnie Zimmer, Deborah Persaud, Mutsa Bwakura-Dangarembizi, Kimesh Naidoo, Rohan Hazra, Patrick Jean-Philippe, Ellen Chadwick. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study. Lancet HIV. 2021. PMID: 33242457

Journal

Lancet HIV

Study

P1115

IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes ofImplementation

Jennifer Libous, Nicole A. Montañez, Geri R. Donenberg, Dorothy E. Dow, Suad Kapetanovic, Janice Buckley, Tebogo Jacqueline Kakhu, Portia Kamthunzi, Limbika A. Maliwichi, Tichaona Vhembo, Tariro Dianah Chawana, Teacler Nematadzira. IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation. Frontiers in Reproductive Health. 2021. 3

Journal

Frontiers in Reproductive Health

Study

IMPAACT 2016

Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development

Sherry Zhao, Mary Gockenbach, Manuela Grimstein, Hari Cheryl Sachs, Mark Mirochnick, Kimberly Struble, Yodit Belew, Jian Wang, Edmund B Capparelli, Brookie M Best, Tamara Johnson, Jeremiah D Momper, Anil R Maharaj. Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development. Frontiers in Pediatrics. 2021. PMID: 34722417

Journal

Frontiers in Pediatrics

Study

P1026S

Pharmacokinetics of tenofovir alafenamide with boosted protease inhibitors in pregnant and postpartum women living with HIV in the United States: Results from IMPAACT P1026s

Kristina M. Brooks, Mauricio Pinilla, Alice M. Stek, David E. Shapiro, Emily Barr, Irma L. Febo, Mary E. Paul, Jaime G. Deville, Kathleen George, Kevin Knowles, Kittipong Rungruengthanakit, Renee Browning, Nahida Chakhtoura, Edmund V. Capparelli, Mark Mirochnick, Brookie M. Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of tenofovir alafenamide with boosted protease inhibitors in pregnant and postpartum women living with HIV in the United States: Results from IMPAACT P1026s. Journal of Acquired Immune Deficiency Syndromes. 2022. PMID: 35195573

Journal

Journal of Acquired Immune Deficiency Syndromes

Study

P1026S